Alere Medical Inc. and its now-defunct subsidiary Arriva Medical LLC have agreed to pay $160m to settle allegations that they violated the False Claims Act (FCA), including billing Medicare for diabetic testing supplies for dead beneficiaries and failing to collect Medicare copays from living ones.
The US Department of Justice announced the deal on 2 August. The DOJ said Arriva, a vendor of diabetic supplies, “paid kickbacks to Medicare beneficiaries by providing them ‘free’...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?